Measures | Baseline | End of treatment | Follow-up |
---|---|---|---|
 |  | at 4 weeks after randomization | at 8, 12, 16, 20 and 24 weeks after randomization |
Informed consent | x | - | - |
Inclusion/exclusion criteria | x | - | - |
Randomization | x | - | - |
Demographic information taking | x | - | - |
Blood pressure | x | x | x |
Blood test | x | x | - |
General assessment | - | x | - |
BMI (body mass index) | x | x | x |
NDI (neck disability index) | x | x | x |
EQ-5D (EuroQol) | x | x | x |
PSQI (Pittsburgh Sleep Quality Index) | x | x | x |
HRV (heart rate variability) | x | x | x |
Questionnaire of pattern identification | x | x | x |
SRI-MF (modified form of the Stress Response Inventory) | x | x | x |
FSS (Fatigue Severity Scale) | x | x | x |
Adverse events | - | x | x |